← All Coeptis Therapeutics Holdings, INC filings

Coeptis Therapeutics Holdings, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
COEP
Coeptis Therapeutics Holdings, INC
DEF 14A: Coeptis Therapeutics Holdings Seeks Stockholder Approval for Reverse Stock Split and $20 Million Equity Issuance
Coeptis Therapeutics Holdings is asking shareholders to approve a reverse stock split and the issuance of up to $20 million in securities at its upcoming annual meeting.